Baillie Gifford - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 10 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,336
-59.4%
3,7110.0%0.00%
Q4 2022$3,288
-45.2%
3,7110.0%0.00%
Q3 2022$6,000
-33.3%
3,711
-14.0%
0.00%
Q2 2022$9,000
-10.0%
4,3140.0%0.00%
Q1 2022$10,000
-50.0%
4,3140.0%0.00%
Q4 2021$20,000
-39.4%
4,3140.0%0.00%
Q3 2021$33,000
-34.0%
4,314
-16.3%
0.00%
Q2 2021$50,000
+8.7%
5,152
-6.9%
0.00%
Q1 2021$46,000
+31.4%
5,531
+8.3%
0.00%
Q4 2020$35,0005,1090.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,623,533$22,851,0006.45%
Avoro Capital Advisors LLC 1,146,579$9,987,0003.44%
Cormorant Asset Management, LP 2,095,334$18,250,0002.18%
Healthcare Value Capital, LLC 50,000$436,0000.72%
CAPITAL MANAGEMENT ASSOCIATES /NY/ 20,000$174,0000.25%
SABBY MANAGEMENT, LLC 300,000$2,613,0000.14%
STRATEGIC INVESTMENT MANAGEMENT, LLC 20,398$177,0000.10%
Granite Investment Partners, LLC 89,622$781,0000.07%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 54,634$476,0000.06%
Trexquant Investment LP 67,929$592,0000.05%
View complete list of SORRENTO THERAPEUTICS INC shareholders